ENT Scope Tower and Stroboscopy Financing for Otolaryngologists

Tower and strobe on one facility

Bundle the VISERA or OTV tower, chip-tip ENF scopes, a KayPENTAX stroboscopy suite, and capture software into one payment instead of two vendor contracts and two due dates.

Bill on nearly every laryngoscopy

Flexible laryngoscopy (CPT 31575) and stroboscopy (31579) earn per visit. We size the term so the monthly payment sits well below the revenue the scope generates in daily use.

Chip-tip and stroboscopy together

A distal-chip ENF-VH2 gives you an image sharp enough to show the patient, and the Model 9400 strobe turns a hoarseness visit into a documented, reimbursable voice exam. We finance both.

All credit profiles welcome

We underwrite the practice and its laryngoscopy volume, not just a bureau score. Challenged credit is priced up front, and a busy in-office scope program is a strong file regardless.

A complete in-office ENT endoscopy suite has three parts, and it helps to price them separately before financing them together.

The imaging platform is usually an Olympus VISERA tower (the OTV-S7 or VISERA Elite II) or a comparable video system, matched to at least one chip-tip flexible scope. The ENF-VH2 and ENF-VT3 put the CMOS chip at the tip of the scope, so the image is sharper than the old fiberoptic bundles and it holds up on a big monitor during a patient consult. Most practices keep two scopes in rotation so one is always reprocessed and ready.

The stroboscopy suite is what separates a general ENT setup from a laryngology-capable one. A KayPENTAX (PENTAX Medical) Model 9400 rhino-laryngeal strobe or the Digital Strobe 9410, paired with capture software, lets you assess mucosal wave and vibratory function and bill for it. This is the piece that turns a hoarseness visit into a documented, reimbursable stroboscopy exam.

The capture and documentation layer, image and video storage, printing, and EMR integration, ties it together and supports your coding.

You do not have to buy all three at once, but financing them on one facility is usually cleaner than stacking separate vendor contracts. We quote the tower, the scopes, the strobe, and the software as a single number and one monthly payment.

A sample of ENT scope and stroboscopy deals we have funded. Rates reflect the practice profile and are never guaranteed.

• Tampa, FL, solo otolaryngologist (5 years in practice): 88,000 dollars for a KayPENTAX Model 9400 stroboscopy suite, two Olympus ENF-VH2 chip-tip scopes, and a VISERA tower. FICO 701. Approved at 5.74% APR, 60 months, 10 percent down.
• Charlotte, NC, three-physician ENT group (12 years): 132,000 dollars to equip three rooms with VISERA Elite II towers and ENF-VT3 scopes. FICO 728. Approved at 5.49% APR, 60 months, 10 percent down.
• Las Vegas, NV, solo laryngologist (2 years): 46,500 dollars for a KayPENTAX Digital Strobe 9410 and one chip-tip scope. FICO 649. Approved at 6.49% APR, 48 months, no money down with the first payment deferred 60 days.
• Grand Rapids, MI, two-physician ENT practice (8 years): 71,000 dollars for an Olympus VISERA tower, an ENF-VH2 and ENF-VT3 scope, and image capture. FICO 664. Approved at 6.24% APR, 60 months, 5 percent down.

A brand-new laryngology practice and a twelve-year group both got funded. Working 500-plus lenders is how we match the file to the right approval.

Flexible laryngoscopy (CPT 31575) is billable at almost every ENT visit where you scope, and diagnostic stroboscopy (31579) adds a separate, better-paying line whenever you assess the voice. Add FEES for swallowing evaluations (92612) and the in-office scope becomes one of the busiest revenue centers in the practice. The comparison that matters: when you scope in the room, you capture the professional and, in many settings, a facility component; when you refer the stroboscopy out, you capture nothing and you lose the follow-up.

On the tax side, Section 179 lets a practice deduct the full cost of qualifying equipment placed in service in the same tax year, up to the 2026 cap of 2.5 million dollars, instead of depreciating a scope tower across five or seven years. On an 88,000 dollar stroboscopy build, a practice in a 32 percent bracket sees roughly 28,000 dollars in first-year tax savings. One hundred percent bonus depreciation is available again for equipment placed in service after January 19, 2025, so anything beyond the Section 179 limit is still fully deductible. Financed equipment qualifies the same as a cash purchase, which means you can take the full deduction this year and spread the payments over five. Your CPA should confirm the numbers for your entity, but the tax treatment is a big part of why our ENT clients finance before December 31.

If you are still running fiberoptic scopes, the upgrade to distal-chip is not just an image-quality nicety, it changes what you can document and bill.

Fiberoptic scopes send light back through a bundle of glass fibers. They work, but the image softens, the honeycomb pattern shows on a big screen, and it is harder to make the case for stroboscopy documentation that holds up. They are also fragile: a few broken fibers and the picture degrades.

Distal-chip scopes like the Olympus ENF-VH2 and ENF-VT3 put a CMOS sensor at the tip. The result is a clean, bright image you can show the patient on a monitor mid-visit, capture cleanly for the chart, and pair with stroboscopy for a defensible voice exam. Patients see their own vocal folds, which does real work for consent and treatment buy-in.

The financing angle is simple. A single distal-chip scope can run 15,000 to 25,000 dollars, and a full tower plus two scopes plus a KayPENTAX strobe reaches six figures fast. Paying cash out of one quarter's collections is painful. Financing the upgrade on a 48 to 60 month term keeps the payment well under the incremental revenue the new capability generates, so the better equipment funds itself while it is in your hand. We can also finance the tower now and let you add a second scope to the same relationship later.

What ENT equipment can I finance?

Video towers (Olympus VISERA Elite II, OTV-S7), chip-tip flexible scopes (ENF-VH2, ENF-VT3), KayPENTAX and PENTAX Medical stroboscopy systems (Model 9400, Digital Strobe 9410), image capture and documentation software, carts, and monitors. New and refurbished both qualify.

Can I finance a KayPENTAX stroboscopy system?

Yes. Stroboscopy suites are one of the most common ENT items we fund. We finance the strobe light source, the rhino-laryngeal scope, and the capture software as one line, on its own or bundled with your tower and flexible scopes.

Do you cover the tower, scopes, and capture software together?

We do. Financing the imaging platform, the scopes, and the documentation layer on a single facility is cleaner than splitting the project across vendor contracts, and it gives you one monthly payment for the entire suite.

What if my credit is challenged?

We accept all credit profiles and underwrite the practice, not just the score. Challenged files carry higher pricing, disclosed before you sign, and often a slightly larger down payment, but a practice with steady laryngoscopy volume is a strong file regardless of a bruised bureau report.

How long is a typical term?

Most ENT scope and stroboscopy deals run 48 to 60 months. We size the term so the monthly payment stays comfortably below the revenue the equipment generates once it is in daily use.

Can I add a second scope later?

Yes. Many clients finance a tower and one scope now, then add a second scope to the same lender relationship later, often with minimal repaperwork. We build the initial deal with that flexibility in mind.